Stay updated on REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial

Sign up to get notified when there's something new on the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:34:50.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Padova, Italy is added and Padua, Italy is removed from the Italy study locations.
    Difference
    0.0%
    Check dated 2026-04-09T21:35:44.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Naples, Italy was added to the locations list and Napoli, Italy was removed from the locations list.
    Difference
    0.0%
    Check dated 2026-03-26T11:29:10.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T04:21:03.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-11T20:20:39.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the previous notices including Revision: v3.4.1 related to government funding and operating status.
    Difference
    0.3%
    Check dated 2026-02-11T10:15:51.000Z thumbnail image

Stay in the know with updates to REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the REFINE: Natalizumab Regimens in Relapsing MS Clinical Trial page.